About the 2017 Astellas Oncology C3 Prize

About the Astellas Oncology C3 Prize

What is the Astellas Oncology C3 Prize?

The Astellas Oncology C3 Prize is a challenge aimed at inspiring non-medicine and non-treatment innovation to change cancer care for patients and their loved ones. The cancer care continuum encompasses all phases of care during illness, from diagnosis to the end of life.1

Five prizes will be awarded as follows: one $50,000 grant and four $12,500 grants. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. The five grant winners will also receive a one-year nights and weekends membership to MATTER, a healthcare innovation community.

The Astellas Oncology C3 Prize is subject to all applicable federal, state, provincial and local laws and regulations. Astellas Pharma reserves the right to change, alter, or modify these rules and/or dates at any time without notice.

What sort of ideas is the Astellas Oncology C3 Prize looking for?

The Astellas Oncology C3 Prize is looking for an idea to develop a new innovation that addresses a major issue in cancer care including but not limited to, one of the following areas:

  • Navigation – Innovative tools, methods or processes are needed to help guide patients living with cancer and their loved ones through the healthcare system and to reduce the burden of decision making, so that patients are able to better focus on their personal health.
  • Adherence – Innovative tools, methods or processes are needed to help patients living with cancer be more successful in adhering to a treatment plan and to help increase medication compliance.
  • Care Coordination – Innovative tools, methods or processes are needed to provide clarity and ease to patients living with cancer and caregivers around improving how care is networked, coordinated and delivered.
  • Survivorship – Innovative tools, methods or processes are needed to develop support systems for patients, caregivers and others impacted by cancer as more people live longer with the disease or live longer cancer-free.

Entrants should let us know what they think the biggest problem is, their idea/solution and the potential impact of that idea/solution in the cancer community.

Learn more about last year’s winners and their ideas.

Application Requirements and Deadlines

When does the Astellas Oncology C3 Prize contest begin and when will the winners be announced?

The 2017 Astellas Oncology C3 Prize challenge has concluded – stay tuned for announcements regarding the 2018 C3 Prize.

Who is eligible to apply?

The 2017 Astellas Oncology C3 Prize challenge has concluded – stay tuned for announcements regarding the 2018 C3 Prize. For more information on the 2017 C3 Prize, please see the Terms and Conditions

Who is not eligible to apply?

The 2017 Astellas Oncology C3 Prize challenge has concluded – stay tuned for announcements regarding the 2018 C3 Prize. For more information on the 2017 C3 Prize, please see the Terms and Conditions

How do I apply for the Challenge?

The 2017 Astellas Oncology C3 Prize challenge has concluded – stay tuned for announcements regarding the 2018 C3 Prize.

How many times can I apply?

Only one application per individual or group will be accepted.

Winner Selection and Prize Rules

How many winners will be selected? How will we know who has won?

Five finalists were invited to pitch their ideas live and all will be awarded grants, with one Grand Prize Winner selected following the live pitch. The Astellas Oncology C3 Prize milestones were as follows:

  • The 2017 Challenge opened on June 19, 2017.
  • Five finalists were invited to pitch their ideas in front of a live panel of judges at the UICC World Cancer Leaders’ Summit on November 13, 2017.
  • The Grand Prize Winner of the Astellas Oncology C3 Prize was announced at the closing reception of the UICC World Cancer Leaders’ Summit on November 14th, 2017.

How were the finalists and grand prize winner selected?

Online forms, videos and live presentations were evaluated by the judges based on the following criteria: plausibility of idea (35%), creativity and originality of innovation (35%) and the ability of entrant to operationalize/implement the innovative idea for future application (30%). All decisions made by the judging panel are final. See the 2017 Terms & Conditions for more information on judging criteria.

What will the winner(s) of the Astellas Oncology C3 Prize receive?

Five prizes will be awarded: One Grand Prize Winner will receive a $50,000 grant and the remaining four finalists will each be awarded a $12,500 grant. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. All five grant winners will also receive a one-year nights and weekends membership to MATTER, a healthcare innovation community.

How can the 2017 Astellas Oncology C3 Prize grant money be used?

The Astellas Oncology C3 Prize grant can be used to bring the winners’ ideas to life. Astellas may also, at its sole discretion, assist Runner/s Up in developing his/her idea.

What is the MATTER membership?

MATTER is built for entrepreneurs and innovators in the fields of medical device, healthcare IT, medical diagnostics and biopharmaceuticals who are looking for flexible, affordable co-working space, mentoring and resources with which to grow their companies. MATTER’s one-year nights and weekends membership will vary based on location of winners, but will include perks such as access to MATTER, use of community workspaces and access to the MATTER mentor network. For more information, visit www.matterchicago.com.

Who chooses the finalists and grand prize winner?

Online forms, videos and live presentations will be judged by a panel of experts.

If I have questions that aren’t addressed here, where can I get more information?

If you have additional questions, please contact the program administrator at C3Prize@astellas.com.

Read the Terms & Conditions